Data monitoring committees (DMCs), also called data and safety monitoring boards (DSMBs), were established in the early 1960s to help maintain the scientific integrity and ethical conduct of clinical trials. DMC oversight continues to increase for clinical trials sponsored by pharmaceutical and medical device companies.
A formal DMC is usually created to
Since the client typically does not have access to interim data results, DMC members are generally independent of anyone that is sponsoring, organizing, or conducting the clinical trial. The Food and Drug Administration (FDA) has recommended that an independent statistical group that has no other responsibilities for the clinical trial generate the reports for DMC review, allowing the client company to remain masked to any interim results.
Westat has experience providing support for DMCs in the following ways
In providing these services, we adhere to the regulations guiding DMC activities.